Study title: Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Jamali F, Barrington KJ, Finer NN, Coutts RT, Torok-Both GA. Dev Pharmacol Ther. 1988;11(5):253-7.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Doxapram | |||||
ATC code: R07AB01 | |||||
Document link: | |||||
Document date: 2015-01-29 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | Y | - | - |